Search - tctmd.com

Displaying 321 - 340 of 381

Sort: Relevancy | Date

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Industry News

FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures

July 25, 2012

News Daily News

Dramatic Increase Seen Nationwide in Advanced Imaging, Radiation Exposure

L.A. McKeown

June 13, 2012

News Daily News

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Caitlin E. Cox

June 11, 2012

News Daily News

Un Registro del Depto. de Veteranos confirma Beneficios a Largo plazo derivados de la Administración de Clopidogrel por encima de los 12 Meses

Caitlin E. Cox

June 11, 2012

Presentation TVT 2012

The Essential Role of CT Planning and TEEGuidance to Optimize Device Deployment

Presenter: John Carroll

June 05, 2012

Presentation TVT 2012

The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment

Presenter: John Carroll

June 05, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Daily News

Local Anesthesia Feasible, Safe in Transfemoral TAVR

May 11, 2012

News Daily News

European Professional Societies Outline Current TEVAR Practices

Caitlin E. Cox

May 10, 2012

News Daily News

Operator Radiation Dose Still Higher with Radial Access Despite Patient Shielding

L.A. McKeown

April 23, 2012

News Daily News

La Dosis de Radiación que Recibe el Operador sigue siendo Más Alta con el Abordaje Radial, Pese a la Protección del Paciente

L.A. McKeown

April 23, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Daily News

Action Plan to Optimize Radiation Safety of Cardiovascular Imaging Developed

March 29, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

News Daily News

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

L.A. McKeown

March 15, 2012

News Daily News

La OCT Revela una Cierta Capacidad para Identificar Lesiones Severas a Nivel Hemodinámico

L.A. McKeown

March 15, 2012

News Daily News

Upfront Measures Shorten Transfer Time to Primary PCI

March 06, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

Advertisement

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures

Dramatic Increase Seen Nationwide in Advanced Imaging, Radiation Exposure

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Un Registro del Depto. de Veteranos confirma Beneficios a Largo plazo derivados de la Administración de Clopidogrel por encima de los 12 Meses

The Essential Role of CT Planning and TEEGuidance to Optimize Device Deployment

The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Local Anesthesia Feasible, Safe in Transfemoral TAVR

European Professional Societies Outline Current TEVAR Practices

Operator Radiation Dose Still Higher with Radial Access Despite Patient Shielding

La Dosis de Radiación que Recibe el Operador sigue siendo Más Alta con el Abordaje Radial, Pese a la Protección del Paciente

TAVR Suitable Even in Patients with Impaired LVEF

Action Plan to Optimize Radiation Safety of Cardiovascular Imaging Developed

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

La OCT Revela una Cierta Capacidad para Identificar Lesiones Severas a Nivel Hemodinámico

Upfront Measures Shorten Transfer Time to Primary PCI

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content